ORAGENICS, INC. Deposits Assets
ORAGENICS, INC. (OGEN) had Deposits Assets of $17.94 thousand as of 2022-09-30, per its 10-Q/A filed 2023-04-14.
Discontinued › Balance Sheet › Assets
us-gaap:DepositsAssets · last filed 2023-04-14
- 2022-09-30: Deposits Assets $17.94K.
- 2022-06-30: Deposits Assets $17.94K.
- 2021-12-31: Deposits Assets $17.94K.
| Period end | Deposits Assets |
|---|---|
| 2022-09-30 | $17.94K 10-Q/A · filed 2023-04-14 |
| 2022-06-30 | $17.94K 10-Q/A · filed 2023-04-14 |
| 2021-12-31 | $17.94K 10-Q/A · filed 2023-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |